Intas Pharmaceuticals Limited Telmisartan Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Telmisartan Export Records India — #3 Exporter, 461 Shipments, $15.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Telmisartan

India Pharmaceutical Trade Intelligence

$11.0B413 Suppliers132 CountriesHS 30049079

ExportsIndia → GERMANY98.4%India → HUNGARY0.5%

ImportsGERMANY → India$1.9B MALTA → India$18.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Intas Pharmaceuticals Limited — Telmisartan Exporter #3 | $15.5M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Telmisartan Exporter Profile

Indian Pharmaceutical Exporter · #3 for Telmisartan · $15.5M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Telmisartan with $15.5M in export value and 461 verified shipments. Intas Pharmaceuticals Limited holds a 0.1% market share in Telmisartan exports across 19 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Telmisartan Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Telmisartan export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Telmisartan?

Country	Value	Shipments	Share
MEXICO	$5.3M	286	72.2%
PHILIPPINES	$663.2K	33	9.0%
CHILE	$467.8K	19	6.3%
NETHERLANDS	$267.7K	58	3.6%

Who Are the Top Buyers of Telmisartan from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD FARMA S.A. DE C.V.	MEXICO	$3.1M	218
ACCORD FARMA S A DE C V	MEXICO	$2.0M	61
TO THE ORDER	TANZANIA	$541.8K	35
RITEMED PHILS., INC.	PHILIPPINES	$286.5K	18
LABORATORIOS SAVAL S.A.	CHILE	$238.4K	8
RITEMED PHILS INC	PHILIPPINES	$148.5K	6
BROCACEF NL : HUB	NETHERLANDS	$129.6K	38
APOTHECA MARKETING PTE. LIMITED	SINGAPORE	$119.8K	3
LABORATORIOS SAVAL S A	CHILE	$111.1K	5
APOTHECA MARKETING PTE. LTD.	SINGAPORE	$105.5K	9

Intas Pharmaceuticals Limited supplies Telmisartan to 34 buyers globally. The largest buyer is ACCORD FARMA S.A. DE C.V. (MEXICO), followed by ACCORD FARMA S A DE C V (MEXICO) and TO THE ORDER (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Telmisartan Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER INV	$1.5M	86
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10TACC-MXE2 AS PER INV	$1.2M	37
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T(ACC-MX)E2 AS PER INVTBS	$871.2K	78
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T ACC MX E2 AS PER INV	$602.5K	17
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER INVTBS	$377.2K	33
PHARMACEUTICAL DRUGS AND MEDICINE - LESPREK 40MG TELMISARTAN 3X10T(ACC-MX)E2 ASPER INVOICE	$251.1K	7
PHARMA DRUG&MED: TELLMI TELMISART.40MG EACH UNCOATED TABLET CONTAINS: TELMISARTAN PH.EUR. 40 MG	$232.3K	5
PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T(ACC-MX) AS PER INVTBS	$133.0K	9
PHARMA DRUGS AND MEDI TELMISARTAN 80MG 3X10T PP (RITEMED - PH) AS PER INV	$116.5K	5
PHARM DRUG&MED:TELMISARTAN 40MG 3X10T PP(RITEMED - PH)EACH UNCOATED TABLET CONTAINS: TELMISARTAN PH. EUR. 40 MGTBS	$111.7K	6

Intas Pharmaceuticals Limited exports 105 distinct Telmisartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER with 86 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Telmisartan Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$81.0M	1,619	5	$50.0K
3	INTAS PHARMACEUTICALS LIMITED ★	$15.5M	461	19	$33.7K
2	MYLAN LABORATORIES LIMITED	$12.0M	240	4	$50.0K
4	ARISTO PHARMACEUTICALS PRIVATE LIMITED	$11.6M	334	10	$34.8K

Intas Pharmaceuticals Limited ranks #3 among 413 Indian Telmisartan exporters. Average shipment value of $33.7K compared to the market average of $416.8K. The closest competitors by value are CIPLA LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Telmisartan Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,766	15.9%
SAHAR AIR	1,729	15.6%
DELHI AIR CARGO ACC (INDEL4)	1,003	9.0%
NHAVA SHEVA SEA (INNSA1)	755	6.8%
DELHI AIR	623	5.6%
AHEMDABAD AIR	402	3.6%
Bombay Air	396	3.6%
JNPT	377	3.4%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Telmisartan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Telmisartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 479 individual customs records matching Intas Pharmaceuticals Limited exporting Telmisartan, covering 105 formulations to 19 countries via 34 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 132+ countries, 1,116+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Telmisartan

Telmisartan

Intas Pharmaceuticals Limited — Telmisartan Exporter Profile

Intas Pharmaceuticals Limited — Telmisartan Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Telmisartan?

Who Are the Top Buyers of Telmisartan from Intas Pharmaceuticals Limited?

What Is India's Total Telmisartan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Telmisartan Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Telmisartan Exporters?

What Telmisartan Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Telmisartan to Key Markets

Mexico — COFEPRIS

How Does Intas Pharmaceuticals Limited Compare to Nearest Telmisartan Exporters?

Which Indian Ports Ship Telmisartan Exports?

What Other Cardiovascular Products Does Intas Pharmaceuticals Limited Export?

Telmisartan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Telmisartan Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Telmisartan Export Data from Intas Pharmaceuticals Limited

Telmisartan Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source